FDA conducts inspection at Global Ocean Trading, LLC in Alhambra on June 11, 2024

Mark Raza Principal Deputy Chief Counsel - FDA
Mark Raza Principal Deputy Chief Counsel - FDA - Official Website
0Comments

During an FDA inspection on June 11, 2024, Global Ocean Trading, LLC in Alhambra was issued five citations concerning foodborne biological hazards, according to data posted on the FDA’s website.

The FDA website indicates that the citations were delivered to the company as follows:

  • ‘You did not develop an FSVP.’
  • ‘You did not document your review and assessment of a hazard analysis conducted by another entity and that a hazard analysis conducted by another entity was conducted by a qualified individual.’
  • ‘You did not document that you conducted an evaluation or reviewed and assessed an evaluation conducted by another entity to determine a foreign supplier’s performance and the risk posed by a food.’
  • ‘You did not establish written procedures for ensuring that appropriate foreign supplier verification activities are conducted with respect to a food you import.’
  • ‘You did not determine and document which verification activity or activities were needed to provide adequate assurances that a food you obtain from a foreign supplier is produced in compliance with processes and procedures that provide the required level of public health protection.’

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Mehmet Oz CMS Administrator

Medicaid spending for surgery services in Monterey Park climbs 11.2% in 2024

Medicaid billings for the Surgery category increased by 11.2% in Monterey Park in 2024, highlighting shifts in care utilization and payment trends.

Dr. Mehmet Oz CMS Administrator

Alhambra Medicaid spending on anesthesia rises to $1,317,128 in 2024

Medicaid payments for anesthesia services in Alhambra surged 102.4% in 2024, reflecting shifts in how care is delivered and reimbursed.

Dr. Mehmet Oz CMS Administrator

West Hollywood Medicaid spending for Medicine Services and Procedures reaches $310,155 in 2024

Medicaid disbursements for the Medicine Services and Procedures category climbed 65.8% in 2024 in West Hollywood, highlighting shifts in both service usage and payment structures.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from LAX Leader.